Advanced Cell Diagnostics Raises $12M in Series B Round | GenomeWeb

NEW YORK (GenomeWeb News) – Advanced Cell Diagnostics today said that it completed its $12 million Series B equity financing round to support the commercial expansion of its RNA biomarker technology.

New Leaf Venture Partners and existing investor Morningside Ventures participated in the round.

The funding will go toward further commercialization of Advanced Cell's RNAscope-based products and services into the life science research market, as well as toward acceleration of RNAscope into the clinical diagnostics space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.